Resultats globals: 2 registres trobats en 0.02 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
9 p, 1.0 MB Improved survival after acute graft-versus-host disease diagnosis in the modern era / Khoury, Hanna J. (Winship Cancer Institute of Emory University) ; Wang, Tao (Medical College of Wisconsin) ; Hemmer, Michael T. (Medical College of Wisconsin) ; Couriel, Daniel (Utah Blood and Marrow Transplant) ; Alousi, Amin (The University of Texas MD Anderson Cancer Center) ; Cutler, Corey (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Aljurf, Mahmoud (King Faisal Specialist Hospital and Research Centre (Aràbia Saudita)) ; Battiwalla, Minoo (Lung and Blood Institute-NIH) ; Cahn, Jean Yves (University Hospital) ; Cairo, Mitchell (New York Medical College) ; Chen, Yi-Bin (Massachusetts General Hospital) ; Gale, Robert Peter (Imperial College London) ; Hashmi, Shahrukh (King Faisal Specialist Hospital and Research Centre (Aràbia Saudita)) ; Hayashi, Robert J. (Washington University School of Medicine in St. Louis) ; Jagasia, Madan (Vanderbilt University Medical Center) ; Juckett, Mark (University of Wisconsin Hospital and Clinics) ; Kamble, Rammurti T. (Baylor College of Medicine) ; Kharfan-Dabaja, Mohamed (H. Lee Moffitt Cancer Center and Research Institute) ; Litzow, Mark (Mayo Clinic Rochester) ; Majhail, Navnnet (Cleveland Clinic Taussig Cancer Institute) ; Miller, Alan (Baylor College of Medicine) ; Nishihori, Taiga (H. Lee Moffitt Cancer Center and Research Institute) ; Qayed, Muna (Emory University School of Medicine) ; Antin, Joseph H. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Schoemans, Helene (University Hospitals Leuven (Bèlgica)) ; Schouten, Harry C. (Academische Ziekenhuis) ; Socie, Gerard (Hopital Saint Louis) ; Storek, Jan (University of Calgary) ; Verdonck, Leo (Isala Clinics Zwolle) ; Vij, Ravi (Washington University School of Medicine) ; Wood, Willian A. (University of North Carolina) ; Yu, Lolie (Children's Hospital/Louisiana State University Medical Center) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Carabasi, Matthew (Thomas Jefferson University Hospital) ; Dandoy, Christopher (Cincinnati Children's Hospital Medical Center) ; Gergis, Usama (New York Presbyterian Hospital/Weill Cornell Medical Center) ; Hematti, Peiman (University of Wisconsin Hospital and Clinics) ; Solh, Melham (The Blood and Marrow Transplant Group of Georgia) ; Jamani, Kareem (University of Calgary) ; Lehmann, Leslie (Boston Children's Hospital (Boston, Estats Units d'Amèrica)) ; Savani, Bipin (Vanderbilt University Medical Center) ; Schultz, Kirk R. (The University of British Columbia) ; Wirk, Baldeep M. (Seattle Cancer Care Alliance) ; Spellman, Stephen (Center for International Blood and Marrow Transplant Research) ; Arora, Mukta (University of Minnesota Medical Center) ; Pidala, Joseph (H. Lee Moffitt Cancer Center and Research Institute) ; Universitat Autònoma de Barcelona
Acute graft-versus-host disease remains a major threat to a successful outcome after allogeneic hematopoietic cell transplantation. While improvements in treatment and supportive care have occurred, it is unknown whether these advances have resulted in improved outcome specifically among those diagnosed with acute graft-versus-host disease. [...]
2017 - 10.3324/haematol.2016.156356
Haematologica, Vol. 102 Núm. 5 (30 2017) , p. 958-966  
2.
13 p, 850.9 KB Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation / Chhabra, Saurabh (Medical College of Wisconsin) ; Liu, Ying (Medical College of Wisconsin) ; Hemmer, Michael T. (Medical College of Wisconsin) ; Costa, Luciano (University of Alabama at Birmingham. Department of Medicine) ; Pidala, Joseph A. (H. Lee Moffitt Cancer Center and Research Institute) ; Couriel, Daniel R. (Utah Blood and Marrow Transplant Program) ; Alousi, Amin M. (University of Texas MD Anderson Cancer Center) ; Majhail, Navneet S. (Cleveland Clinic Taussig Cancer Institute) ; Stuart, Robert K. (Medical University of South Carolina) ; Kim, Dennis (Princess Margaret Cancer Center) ; Ringden, Olle (Karolinska Institutet (Estocolm, Suècia). Division of Therapeutic Immunology) ; Urbano Ispizua, Álvaro (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Saad, Ayman (University of Alabama at Birmingham) ; Savani, Bipin N. (Vanderbilt University Medical Center) ; Cooper, Brenda (University Hospitals Case Medical Center. Department of Medicine-Hematology and Oncology) ; Marks, David I. (University Hospitals Bristol NHS Trust) ; Socie, Gerard (Hôpital Saint Louis. Department of Hematology) ; Schouten, Harry C. (Academische Ziekenhuis. Department of Hematology) ; Schoemans, Helene (University Hospitals Leuven (Bèlgica)) ; Abdel-Azim, Hisham (University of Southern California Keck School of Medicine) ; Yared, Jean (University of Maryland. Greenebaum Cancer Center) ; Cahn, Jean-Yves (CHU Grenoble Alpes. Department of Hematology) ; Wagner, John (Thomas Jefferson University. Department of Medical Oncology) ; Antin, Joseph H. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Verdonck, Leo F. (Isala Clinic. Departmentt of Hematology/Oncology) ; Lehmann, Leslie (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Aljurf, Mahmoud (King Faisal Specialist Hospital and Research Centre (Aràbia Saudita)) ; MacMillan, Margaret L. (University of Minnesota Blood and Marrow Transplant Program) ; Litzow, Mark R. (Mayo Clinic Rochester. Division of Hematology and Transplant Center) ; Solh, Melhem M. (Northside Hospital. Blood and Marrow Transplant Group of Georgia) ; Qayed, Muna (Emory University School of Medicine. Department of Pediatrics) ; Hematti, Peiman (University of Wisconsin) ; Kamble, Rammurti T. (Baylor College of Medicine) ; Vij, Ravi (Washington University School of Medicine. Division of Hematology and Oncology) ; Hayashi, Robert J. (Washington University School of Medicine in St. Louis. Division of Pediatric Hematology/Oncology) ; Gale, Robert Peter (Imperial College London. Hematology Research Centre) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Seo, Sachiko (National Cancer Research Center East) ; Hashmi, Shahrukh K (Mayo Clinic Rochester. Division of Hematology and Transplant Center) ; Nishihori, Taiga (H. Lee Moffitt Cancer Center and Research Institute) ; Teshima, Takanori (Kyushu University Hospital) ; Gergis, Usama (New York Presbyterian Hospital/Weill Cornell Medical Center. Department of Medical Oncology) ; Inamoto, Yoshihiro (National Cancer Center Hospital) ; Spellman, Stephen R. (Center for International Blood and Marrow Transplant Research) ; Arora, Mukta (University of Minnesota Medical Center) ; Hamilton, Betty K. (Cleveland Clinic Taussig Cancer Institute) ; Universitat Autònoma de Barcelona
The combination of a calcineurin inhibitor (CNI) such as tacrolimus (TAC) or cyclosporine (CYSP) with methotrexate (MTX) or with mycophenolate mofetil (MMF) has been commonly used for graft-versus-host disease (GVHD) prophylaxis after reduced-intensity conditioning (RIC) allogeneic hematopoietic cell transplantation (alloHCT), but there are limited data comparing efficacy of the 2 regimens. [...]
2019 - 10.1016/j.bbmt.2018.08.018
Biology of blood and marrow transplantation, Vol. 25 Núm. 1 (january 2019) , p. 73-85  

Vegeu també: autors amb noms similars
2 Hayashi, Robert J.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.